Green; Daniel Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Green; Daniel Michael.The latest application filed is for "naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system".
- Green; Daniel Michael - Ambler PA
| Patent | Date |
|---|---|
| Gonadotropin releasing hormone receptor antagonists Grant 7,696,210 - Garrick , et al. April 13, 2 | 2010-04-13 |
| Naphthylpyrimidine, Naphthylpyrazine And Naphthylpyridazine Analogs And Their Use As Agonists Of The Wnt-beta-catenin Cellular Messaging System App 20090054392 - Pelletier; Jeffrey Claude ; et al. | 2009-02-26 |
| Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor App 20060264631 - Green; Daniel Michael ; et al. | 2006-11-23 |
| Gonadotropin releasing hormone receptor antagonists App 20060111355 - Garrick; Lloyd Michael ; et al. | 2006-05-25 |
| Gonadotropin releasing hormone receptor antagonists App 20060019965 - Garrick; Lloyd Michael ; et al. | 2006-01-26 |
| Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists App 20020065309 - Peng, Ge ; et al. | 2002-05-30 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 